THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

Antiepileptic Drugs and Vascular Risk Markers

Not Applicable

Terminated

Conditions: Subarachnoid Hemorrhage

Interventions: Drug: phenytoin
Drug: levetiracetam
Drug: valproate

First Posted Date: 2008-10-17

Last Posted Date: 2017-12-18

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 52

Registration Number: NCT00774306

Low Vision Depression Prevention Trial for Age Related Macular Degeneration

Phase 3

Completed

Conditions: Depression
Age-related Macular Degeneration

Interventions: Behavioral: ST-LVR
Behavioral: BA-LVR

First Posted Date: 2008-10-08

Last Posted Date: 2014-11-20

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 188

Registration Number: NCT00769015

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation

Completed

Conditions: Cancer of the Lung
Cancer of the Esophagus
Cancer of the Head and Neck
Gastro-esophageal Junction Cancer

First Posted Date: 2008-07-16

Last Posted Date: 2014-12-05

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 40

Registration Number: NCT00716157

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Improving Function in Age-Related Macular Degeneration

Phase 3

Completed

Conditions: Age-Related Macular Degeneration

Interventions: Behavioral: PST
Behavioral: ST

First Posted Date: 2007-12-12

Last Posted Date: 2015-10-15

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 241

Registration Number: NCT00572039

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Buprenorphine for the Treatment of Neonatal Abstinence Syndrome

Phase 1

Completed

Conditions: Neonatal Abstinence Syndrome

Interventions: Drug: Oral morphine solution
Drug: buprenorphine

First Posted Date: 2007-08-27

Last Posted Date: 2017-01-12

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 60

Registration Number: NCT00521248

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Beat the Blues: Treating Depression in African American Elders

Phase 3

Completed

Conditions: Behavioral Activation Treatment
Depression
Stress Reduction

Interventions: Behavioral: Behavioral Based In-Home Intervention

First Posted Date: 2007-08-06

Last Posted Date: 2012-08-08

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 192

Registration Number: NCT00511680

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM)

Phase 2

Conditions: Preterm Premature Rupture of Membranes

First Posted Date: 2007-04-27

Last Posted Date: 2015-03-18

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 116

Registration Number: NCT00466128

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux

Completed

Conditions: Gastroesophageal Reflux

Interventions: Procedure: Sleep Studies

First Posted Date: 2007-04-18

Last Posted Date: 2019-08-05

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 8

Registration Number: NCT00462137

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin

Phase 4

Completed

Conditions: Hyperhidrosis

Interventions: Drug: terazosin

First Posted Date: 2007-03-20

Last Posted Date: 2016-08-25

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 23

Registration Number: NCT00449683

Locations: 🇺🇸
Thomas Jefferson University, Department of Psychiatry, Philadelphia, Pennsylvania, United States

A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache

Phase 4

Completed

Conditions: Migraine

Interventions: Drug: duloxetine

First Posted Date: 2007-03-06

Last Posted Date: 2014-05-26

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 27

Registration Number: NCT00443352

Locations: 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy